Mobile app developer adds disease-specific modules for patients – and pharma partners

Beth Snyder Bulik

Senior Editor

While pharma companies have struggled to gain traction with mobile apps for patients, one developer is working on a way to help. Smartpatient is launching …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Mobile app developer adds disease-specific modules for patients – and pharma partners

Beth Snyder Bulik

Senior Editor

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Biopharma begins to contemplate an RFK Jr.-influenced FDA if Trump wins

Pfizer shares new details on obesity pipeline, hints at ‘other opportunities’

GSK buys autoimmune T cell engager for $300M upfront from Chimagen

Novartis takes $800M MorphoSys writedown mere months after closing acquisition

Novartis highlights overall M&A track record following MorphoSys impairment

Following March inspection, Novo Nordisk's semaglutide manufacturing facility cited by FDA

Mo­bile app de­vel­op­er adds dis­ease-spe­cif­ic mod­ules for pa­tients – and phar­ma part­ners

Senior Editor

Sign up to read this article for free.

more like this

Viridian Therapeutics

Waltham, MA, USA

Mobile app developer adds disease-specific modules for patients – and pharma partners